Exosome & EV Center

The Exosome & EV Center at ATLATL is designed to help teams develop and validate exosome-based therapeutics and delivery systems faster.

Exosomes offer a promising approach for cell-free therapies and targeted delivery, with advantages in biocompatibility, stability, and tissue penetration (including the blood-brain barrier). At ATLATL, we provide an integrated, end-to-end platform covering isolation, characterization, functional validation, and scalable production.

Located within our bio-hubs, scientists work side-by-side with technical experts, enabling rapid iteration and generation of decision-ready data—from early research through translational development.

Core Capabilities:

Isolation & Purification

High-efficiency, automated isolation from diverse sample types (cell culture, plasma, urine, and more), ensuring high purity, yield, and preserved bioactivity.

Characterization & Quality Control

Comprehensive analysis including:

•Size and concentration (NTA)

•Morphology (TEM / Cryo-EM)

•Surface markers (FACS, WB, NanoFCM)

•Stability and charge (Zeta potential)

Functional Validation

Evaluation of biological activity using cell-based and in vivo models, supported by multi-omics and mechanistic studies.

Engineering & Therapeutic Development

Support for drug loading, targeting modification, and labeling, enabling development of exosome-based delivery systems.

Scale-Up & Manufacturing Support

From small-scale research to pilot and large-scale production, with workflows designed for consistency and reproducibility.